Combination of azacitidine and ESA in myelodysplastic patients: the need for prospective studies

Leuk Res. 2012 Jun;36(6):682-3. doi: 10.1016/j.leukres.2012.02.020. Epub 2012 Mar 17.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage*
  • Azacitidine / administration & dosage*
  • Female
  • Hematinics / administration & dosage*
  • Humans
  • Male
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / mortality*

Substances

  • Antimetabolites, Antineoplastic
  • Hematinics
  • Azacitidine